All posts by: Michael Zand

About Michael Zand

A US panel has endorsed limited genetic modification of humans — here’s what that means – Business Insider UK

Continue reading

2017-02-20 NEWS

Business Insider UK

A US panel has endorsed limited genetic modification of humans — here’s what that means
Business Insider UK
For now it’s hard to apply a genetic editing tool (like CRISPR) to an early embryo and have it make all the changes to a genome that you want (and no unwanted extra changes). When you let that editing tool loose it seeks out the segments of DNA you are …

and more »

Continue reading

2017-02-20 NEWS

Business Insider

National Academies Panel says some germline editing with CRISPR …
Business Insider
These are the sort of conditions scientists have said it’s permissible to edit human genomes for and what will have to happen before that becomes a reality.

and more »

Continue reading

2017-02-20 NEWS

Cx601 stem cell therapy maintains remission of complex perianal fistulas through 1 year in Crohn’s
Healio
Patients with Crohn’s disease achieved sustained remission of treatment-refractory complex perianal fistulas through 52 weeks after treatment with Cx601 stem cell therapy, according to results from the ADMIRE-CD trial presented at the 12th Congress of

and more »

Continue reading

2017-02-20 NEWS

Cx601 stem cell therapy maintains remission of complex perianal fistulas through 1 year in Crohn’s
Healio
Patients with Crohn’s disease achieved sustained remission of treatment-refractory complex perianal fistulas through 52 weeks after treatment with Cx601 stem cell therapy, according to results from the ADMIRE-CD trial presented at the 12th Congress of

and more »

Continue reading

2017-02-20 NEWS

Immunotherapy and the Future of Prostate Cancer Treatment
Oncology Nurse Advisor
ORLANDO, FL – Despite early failures, there may be a role for single-agent and combination immunotherapy for patients with prostate cancer, according to a keynote presentation at 2017 Genitourinary Cancers Symposium.1. Charles G. Drake, MD, PhD, …